BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38560574)

  • 1. The role of polymorphic cytochrome P450 gene (CYP2B6) in B-chronic lymphocytic leukemia (B-CLL) incidence and outcome among Egyptian patients.
    Al-Adl M; Youssef MM; El-Sebaie A; Refaat S; El-Said A
    Oncol Res; 2024; 32(4):785-797. PubMed ID: 38560574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of CYP1A1 T3801C (rs4646903) variant with the susceptibility and progression of B-chronic lymphocytic Leukemia (B-CLL) in the Egyptian population.
    Al-Adl M; El-Said A; El-Sebaie A; Refaat S; Youssef MM
    Gene; 2023 Oct; 883():147673. PubMed ID: 37506988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP2B6*6 is an independent determinant of inferior response to fludarabine plus cyclophosphamide in chronic lymphocytic leukemia.
    Johnson GG; Lin K; Cox TF; Oates M; Sibson DR; Eccles R; Lloyd B; Gardiner LJ; Carr DF; Pirmohamed M; Strefford JC; Oscier DG; Gonzalez de Castro D; Else M; Catovsky D; Pettitt AR
    Blood; 2013 Dec; 122(26):4253-8. PubMed ID: 24128861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of SLC28A3 Gene Expression and CYP2B6*6 Allele with the Response to Fludarabine Plus Cyclophosphamide in Chronic Lymphocytic Leukemia Patients.
    Vukovic V; Karan-Djurasevic T; Antic D; Tosic N; Kostic T; Marjanovic I; Dencic-Fekete M; Djurasinovic V; Pavlovic S; Mihaljevic B
    Pathol Oncol Res; 2020 Apr; 26(2):743-752. PubMed ID: 30778771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The G⁵¹⁶T CYP2B6 germline polymorphism affects the risk of acute myeloid leukemia and is associated with specific chromosomal abnormalities.
    Daraki A; Zachaki S; Koromila T; Diamantopoulou P; Pantelias GE; Sambani C; Aleporou V; Kollia P; Manola KN
    PLoS One; 2014; 9(2):e88879. PubMed ID: 24586425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of CYP2B6 G15631T polymorphism with acute leukemia susceptibility.
    Berköz M; Yalin S
    Leuk Res; 2009 Jul; 33(7):919-23. PubMed ID: 19144407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CYP2B6 G516T polymorphism influences CD4
    Queiroz MAF; Laurentino RV; da Silva Graça Amoras E; Araújo MSM; Gomes STM; Lima SS; Vallinoto ACR; de Oliveira Guimarães Ishak M; Ishak R; Machado LFA
    Int J Infect Dis; 2017 Feb; 55():4-10. PubMed ID: 27940179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allelic and genotype frequencies of major CYP2B6 polymorphisms in the Pakistani population.
    Ahmed S; Khan S; Janjua K; Imran I; Khan AU
    Mol Genet Genomic Med; 2021 Mar; 9(3):e1527. PubMed ID: 33599403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP2B6 gene single nucleotide polymorphisms and leukemia susceptibility.
    Yuan ZH; Liu Q; Zhang Y; Liu HX; Zhao J; Zhu P
    Ann Hematol; 2011 Mar; 90(3):293-9. PubMed ID: 20878158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of alleles, genotypes and haplotypes of the CYP2B6 (rs3745274; rs2279343) and CYP3A4 (rs2740574) genes in the Malian population: Implication for pharmacogenetics.
    Kassogue Y; Diakite B; Kassogue O; Konate I; Tamboura K; Diarra Z; Maiga M; Dehbi H; Nadifi S; Traore CB; Kamate B; Dao S; Doumbia S; Dolo G
    Medicine (Baltimore); 2021 Jul; 100(29):e26614. PubMed ID: 34398016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the selected cytochrome P450 oxidoreductase genetic polymorphisms on cytochrome P450 2B6 activity as measured by bupropion hydroxylation.
    Lv J; Hu L; Zhuo W; Zhang C; Zhou H; Fan L
    Pharmacogenet Genomics; 2016 Feb; 26(2):80-7. PubMed ID: 26580670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of the associations of CYP2B6-516G>T polymorphisms with efavirenz-induced central nervous system side effects and virological outcome in HIV-infected adults.
    Cheng L; Wang Y; Li X; Feng W; Weng B; Yuan Q; Xia P; Sun F
    Pharmacogenomics J; 2020 Apr; 20(2):246-259. PubMed ID: 31636355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of CYP2B6 polymorphisms in Argentinians: the role of genetic testing.
    Scibona P; Vazquez C; Cajal AR; Argibay PF; Belloso WH
    Genet Mol Res; 2015 Dec; 14(4):16594-9. PubMed ID: 26681005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in xenobiotic-metabolizing genes and the risk of chronic lymphocytic leukemia and non-Hodgkin's lymphoma in adult Russian patients.
    Gra OA; Glotov AS; Nikitin EA; Glotov OS; Kuznetsova VE; Chudinov AV; Sudarikov AB; Nasedkina TV
    Am J Hematol; 2008 Apr; 83(4):279-87. PubMed ID: 18061941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereoselective Ketamine Metabolism by Genetic Variants of Cytochrome P450 CYP2B6 and Cytochrome P450 Oxidoreductase.
    Wang PF; Neiner A; Kharasch ED
    Anesthesiology; 2018 Oct; 129(4):756-768. PubMed ID: 30085944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The P450 oxidoreductase (POR) rs2868177 and cytochrome P450 (CYP) 2B6*6 polymorphisms contribute to the interindividual variability in human CYP2B6 activity.
    Gao LC; Liu FQ; Yang L; Cheng L; Dai HY; Tao R; Cao SP; Wang D; Tang J
    Eur J Clin Pharmacol; 2016 Oct; 72(10):1205-1213. PubMed ID: 27439448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allele and Genotype Frequencies of Cytochrome P450 2B6 516G>T Single Nucleotide Polymorphism in HIV-Negative and HIV-Infected Adult Nigerian Populations.
    Saʼad Toyin A; Julius Olugbenga S; Rahman Ayodele B; Olusola Joseph O; Taibat Moji BO
    Am J Ther; 2016; 23(6):e1715-e1719. PubMed ID: 26938766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P450 2B6 516G-->T is associated with plasma concentrations of nevirapine at both 200 mg twice daily and 400 mg once daily in an ethnically diverse population.
    Mahungu T; Smith C; Turner F; Egan D; Youle M; Johnson M; Khoo S; Back Dj; Owen A
    HIV Med; 2009 May; 10(5):310-7. PubMed ID: 19228205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms effect on cyclophosphamide's tolerability and clinical efficacy in Egyptian patients with lupus nephritis.
    Abuelsoud NN; El Khateeb EM
    Pharmacogenet Genomics; 2023 Oct; 33(8):172-180. PubMed ID: 37611146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allelic and Genotype Frequencies of CYP2B6
    Khavandegar A; Tavakoli-Far B; Ansari S; Veis-Karami P; Ghasemi F; Sheibaninia S; Jazayeri R; Houshmand M
    Genet Res (Camb); 2023; 2023():8283470. PubMed ID: 36817260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.